Samsung Medison / Samsung Healthcare
Samsung Healthcare's medical-imaging arm — a major ultrasound OEM with a meaningful share of women's-health, general-imaging, and point-of-care segments globally. The ultrasound business descends from Medison (Korean ultrasound pioneer founded 1985), which Samsung Group acquired and rebranded as Samsung Medison in 2011. Samsung subsequently expanded into digital radiography and mobile X-ray with the GC85A and GM85 platforms, and operates in the CT segment in selected regions through the NeuroLogica subsidiary (acquired 2013) — best known for the BodyTom and CereTom mobile CT units.
Samsung is competitive in the premium ultrasound tier on women's-health 3D / 4D, and is strong globally in mid-market general-imaging ultrasound. Outside ultrasound, the imaging footprint is narrower than the Big Three, with DR / mobile-DR holding meaningful market share but CT, MRI, and PET / nuclear medicine effectively absent from the catalog.
Product line
Ultrasound — premium / women's health
- Samsung WS80A / HERA W10 — premium women's-health flagship.
Digital radiography
- DR fixed-room and mobile DR (GC85A / GM85 platforms — not yet carded).
Mobile / niche CT (via NeuroLogica)
- BodyTom / CereTom mobile CT (NeuroLogica subsidiary — not yet carded).
Distinctive technology
- S-Vue transducers — Samsung's premium volume-imaging probe family.
- CrystalLive / HERA imaging engine — premium imaging architecture for the WS / HERA W lines.
- 5D / S-Detect — automated lesion-detection and biometry workflow tools.
Market position
- Premium ultrasound OEM — credible competitor to GE Voluson and Philips EPIQ in OB / GYN.
- Strong DR presence in mobile / portable X-ray.
- Big Three competitors: GE HealthCare, Philips, Canon Medical.
Refurb posture
- Mature ultrasound refurb supply in OB / GYN and general-imaging tiers.
- S-Vue volume-transducer condition is the cart-driver on premium women's-health refurbs.